A Biobank for Pancreatic Diseases

Overview

About this study

To develop a resource (bank) of biospecimens and data collected from individuals with pancreatic diseases to facilitate discovery and development of novel biomarkers of risk and early detection, severity prediction, etiology and response to therapy.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

 Inclusion Criteria

  • Patients with known or newly-diagnosed pancreatic disease.
  • Age ≥ 18.
  • Individuals must be able to provide informed consent. Pregnant women are eligible

Exclusion Criteria

  • Individuals who do not comprehend English (i.e., participants must be able to read and sign a consent form without the assistance of an interpreter)
  • Age < 18.
  • Individuals who are unable to sign consent (e.g., mentally challenged, those declared legally incompetent).

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lisa Boardman, M.D.

Closed for enrollment

Contact information:

M Felmlee Devine M.S., CCRP

FelmleeDevine.Donna@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20316195

Mayo Clinic Footer